A Study is to Evaluate a Regimen on Gingivitis Using Traditional and Novel Assessment Methods

NCT ID: NCT07211061

Last Updated: 2025-10-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

69 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-09-21

Study Completion Date

2011-11-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Subjects who have shown evidence of gingivitis and plaque will be enrolled in this study. Each subject will be randomly assigned to one of two treatment products. The regimen group will be asked to brush 2x a day in using a power brush (2 minutes of brushing), followed by using 20 ml of mouth rinse for 30 seconds for 6 weeks. The negative control group will be asked to brush 2x a day using a manual toothbrush in their customary manner for 6 weeks. Oral Soft Tissue (OST) assessments, gingivitis and plaque measurements will be taken at 4 time-points: Baseline (BL); Week 1; Week 3; and Week 6.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gingivitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Oral Hygiene Regimen

toothpaste, electric toothbrush, and mouth rinse

Group Type EXPERIMENTAL

Stannous Fluoride Dentifrice

Intervention Type DRUG

brush 2x a day in using a power brush (2 minutes of brushing)

electric toothbrush

Intervention Type DEVICE

brush using a electric brush (2 minutes of brushing)

Cetylpyridinium Chloride (CPC)

Intervention Type DRUG

use 20 ml of mouth rinse for 30 seconds

Negative Control

toothpaste and manual toothbrush

Group Type ACTIVE_COMPARATOR

Sodium Fluoride Dentifrice

Intervention Type DRUG

brush in their customary manner

manual toothbrush

Intervention Type DEVICE

brush in their customary manner

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Stannous Fluoride Dentifrice

brush 2x a day in using a power brush (2 minutes of brushing)

Intervention Type DRUG

Sodium Fluoride Dentifrice

brush in their customary manner

Intervention Type DRUG

electric toothbrush

brush using a electric brush (2 minutes of brushing)

Intervention Type DEVICE

Cetylpyridinium Chloride (CPC)

use 20 ml of mouth rinse for 30 seconds

Intervention Type DRUG

manual toothbrush

brush in their customary manner

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Provide written informed consent to participate in the study;
* Be 18 years of age or older;
* Agree not to participate in any other oral/dental product studies during the course of this study;
* Agree to delay any elective dentistry (including dental prophylaxis) until the study has been completed;
* Agree to refrain from any form of non-specified oral hygiene during the treatment periods, including but not limited to the use of products such as floss or whitening products;
* Have a Baseline MGI score of at least 1.75 but not greater than 2.3;
* Have at least 20 bleeding sites (sites with a score of 1 or 2 on the GBI index);
* Agree to return for all scheduled visits and follow study procedures;
* Be in good general health, as determined by the Investigator/designee based on a review of the health history/update for participation in the study.

Exclusion Criteria

* Have had a dental prophylaxis within 2 weeks of Baseline visit;
* Have taken antibiotics or used anti-gingivitis / anti-bacterial oral care products such as chlorhexidine or Listerine within 2 weeks of plaque sampling visits;
* Have rampant caries, open or untreated caries, severe gingivitis, or advanced periodontitis requiring prompt treatment; or,
* Need an antibiotic prophylaxis prior to dental visits,
* Present with any disease or condition(s) that could be expected to interfere with examination procedures or the subject's safe completion of the study,
* Are pregnant (Self-reported) or lactating.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Procter and Gamble

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Bio-Sci Research (Out of Business)

Las Vegas, Nevada, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2011068

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Clinical Investigation of PerioGard (Test) Regimen
NCT07210138 ACTIVE_NOT_RECRUITING PHASE3
Stannous Fluoride and Gingivitis
NCT05326373 COMPLETED NA
Assessing Gingivitis and Plaque From a Marketed Toothpaste
NCT07158112 ACTIVE_NOT_RECRUITING PHASE4